Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 884970

The Role Of Cyp2d6, Cyp3a4/5, And Abcb1 Polymorphisms In Patients Using Long-Acting Injectable Risperidone

Ganoci, Lana; Lovrić, Mila; Živković, Maja; Šagud, Marina; Klarica Domjanović, Iva; Božina, Nada
The Role Of Cyp2d6, Cyp3a4/5, And Abcb1 Polymorphisms In Patients Using Long-Acting Injectable Risperidone // European Association for Clinical Pharmacology and Therapeutics (EACPT) Focus Meeting 2016 : How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic – 3E Assessment and European Association for Clinical Pharmacology and Therapeutics (EACPT) Focus Meeting 2016 : How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic 3E Assessment : abstracts ; u: Clinical Therapeutics 38 (2016) 10 (S6) A1-A4, e1-e32
Opatija, Hrvatska, 2016. str. e10-e11 (poster, međunarodna recenzija, sažetak, znanstveni)

CROSBI ID: 884970 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
The Role Of Cyp2d6, Cyp3a4/5, And Abcb1 Polymorphisms In Patients Using Long-Acting Injectable Risperidone

Autori
Ganoci, Lana ; Lovrić, Mila ; Živković, Maja ; Šagud, Marina ; Klarica Domjanović, Iva ; Božina, Nada

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
European Association for Clinical Pharmacology and Therapeutics (EACPT) Focus Meeting 2016 : How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic – 3E Assessment and European Association for Clinical Pharmacology and Therapeutics (EACPT) Focus Meeting 2016 : How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic 3E Assessment : abstracts ; u: Clinical Therapeutics 38 (2016) 10 (S6) A1-A4, e1-e32 / - , 2016, E10-e11

Skup
European Association for Clinical Pharmacology and Therapeutics (EACPT) Focus Meeting 2016 : How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic – 3E Assessment ; European Association for Clinical Pharmacology and Therapeutics (EACPT) Focus Meeting 2016 : How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic

Mjesto i datum
Opatija, Hrvatska, 06.10.2016. - 09.10.2016

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
CYP2D6 genotypes, CYP3A4/5 genotypes, P-glycoprotein, Long-acting risperidone

Sažetak
A study of the serum concentration of the active substance of long-acting risperidone was compared to CYP2D6, CYP3A5 and ABCB1 genotypes. Slow metabolizers of CYP2D6 had elevated and ultra fast metabolizers of CYP2D6 reduced concentrations of the active substance. Other genotypes had no effect on the concentration of risperidone + 9-OH risperidone.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

Napomena
DOI: 10.1016/j.clinthera.2016.07.110 ; https://doi.org/10.1016/j.clinthera.2016.07.110



POVEZANOST RADA

Ustanove:
Medicinski fakultet, Zagreb

Profili:

Avatar Url Lana Ganoci (autor)

Avatar Url Nada Božina (autor)

Avatar Url Marina Šagud (autor)

Avatar Url Mila Lovrić (autor)

Avatar Url Maja Živković (autor)

www.sciencedirect.com www.ncbi.nlm.nih.gov

Citiraj ovu publikaciju:

Ganoci, Lana; Lovrić, Mila; Živković, Maja; Šagud, Marina; Klarica Domjanović, Iva; Božina, Nada
The Role Of Cyp2d6, Cyp3a4/5, And Abcb1 Polymorphisms In Patients Using Long-Acting Injectable Risperidone // European Association for Clinical Pharmacology and Therapeutics (EACPT) Focus Meeting 2016 : How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic – 3E Assessment and European Association for Clinical Pharmacology and Therapeutics (EACPT) Focus Meeting 2016 : How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic 3E Assessment : abstracts ; u: Clinical Therapeutics 38 (2016) 10 (S6) A1-A4, e1-e32
Opatija, Hrvatska, 2016. str. e10-e11 (poster, međunarodna recenzija, sažetak, znanstveni)
Ganoci, L., Lovrić, M., Živković, M., Šagud, M., Klarica Domjanović, I. & Božina, N. (2016) The Role Of Cyp2d6, Cyp3a4/5, And Abcb1 Polymorphisms In Patients Using Long-Acting Injectable Risperidone. U: European Association for Clinical Pharmacology and Therapeutics (EACPT) Focus Meeting 2016 : How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic – 3E Assessment and European Association for Clinical Pharmacology and Therapeutics (EACPT) Focus Meeting 2016 : How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic 3E Assessment : abstracts ; u: Clinical Therapeutics 38 (2016) 10 (S6) A1-A4, e1-e32.
@article{article, author = {Ganoci, Lana and Lovri\'{c}, Mila and \v{Z}ivkovi\'{c}, Maja and \v{S}agud, Marina and Klarica Domjanovi\'{c}, Iva and Bo\v{z}ina, Nada}, year = {2016}, pages = {e10-e11}, keywords = {CYP2D6 genotypes, CYP3A4/5 genotypes, P-glycoprotein, Long-acting risperidone}, title = {The Role Of Cyp2d6, Cyp3a4/5, And Abcb1 Polymorphisms In Patients Using Long-Acting Injectable Risperidone}, keyword = {CYP2D6 genotypes, CYP3A4/5 genotypes, P-glycoprotein, Long-acting risperidone}, publisherplace = {Opatija, Hrvatska} }
@article{article, author = {Ganoci, Lana and Lovri\'{c}, Mila and \v{Z}ivkovi\'{c}, Maja and \v{S}agud, Marina and Klarica Domjanovi\'{c}, Iva and Bo\v{z}ina, Nada}, year = {2016}, pages = {e10-e11}, keywords = {CYP2D6 genotypes, CYP3A4/5 genotypes, P-glycoprotein, Long-acting risperidone}, title = {The Role Of Cyp2d6, Cyp3a4/5, And Abcb1 Polymorphisms In Patients Using Long-Acting Injectable Risperidone}, keyword = {CYP2D6 genotypes, CYP3A4/5 genotypes, P-glycoprotein, Long-acting risperidone}, publisherplace = {Opatija, Hrvatska} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
  • Scopus
  • MEDLINE

Podijeli:





Contrast
Increase Font
Decrease Font
Dyslexic Font
CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.